Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

The objective is to use “data, technology, and science to make self-care more precise”, with digital diagnostics ... consistently looking for health solutions that go beyond traditional ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael ... The initiative, named Chronos-PD, could lead to the discovery of new ...

Spanish pharma Grifols is leveraging its massive collection ... “The hope is to accelerate and ultimately develop new diagnostics and disease-modifying therapeutics that could mitigate or ...

leading to new diagnostic tools and disease-modifying therapiesPart of broad Grifols program to find disease-revealing clues in more than 100 million proprietary plasma samples connected to real ...

Will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years.

The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months ... other products like blood transfusion diagnostics, which is tax-domiciled in Ireland ...